Aldosterone, Training, and Exercise: What Your Lab Values Mean for Performance and Health

What Is Aldosterone and Why Does It Matter to Active Patients?

Aldosterone is the primary mineralocorticoid produced by the zona glomerulosa of the adrenal cortex. Its core job is to retain sodium and water in the renal collecting duct while excreting potassium, which directly governs plasma volume and blood pressure. For athletes and people in supervised hormone-therapy programs, aldosterone is not a passive bystander. It shifts with hydration status, sweat rate, dietary sodium, and training load in ways that affect performance, recovery, and cardiovascular risk.

The Renin-Angiotensin-Aldosterone System (RAAS) in Brief

The RAAS cascade begins when the kidneys sense low perfusion pressure or low sodium delivery to the distal tubule. The juxtaglomerular cells release renin, which cleaves angiotensinogen to angiotensin I. Angiotensin-converting enzyme then produces angiotensin II, and angiotensin II is the dominant stimulus for aldosterone secretion. Elevated serum potassium is a second direct stimulus, independent of renin. This dual control makes aldosterone unusually responsive to exercise, which simultaneously depletes sodium through sweat and raises extracellular potassium from working muscle. RAAS physiology is reviewed in detail at the National Library of Medicine.

Why Posture and Timing Change Your Lab Result

Aldosterone values shift substantially based on draw conditions. Upright posture for 30 minutes before blood draw raises aldosterone by approximately 20 to 30% compared with a supine draw, because standing activates baroreceptors and increases RAAS tone. A high-sodium diet suppresses aldosterone, while a low-sodium diet raises it. Most reference laboratories standardize to a fasting, seated, morning draw after the patient has been upright for at least 15 minutes. If your result was drawn after a workout, in the afternoon, or in a sodium-depleted state, the number requires re-interpretation before clinical decisions are made. CDC guidance on specimen collection standardization supports these preanalytical controls.

Aldosterone Normal Range and What "Optimal" Means

The widely cited reference range for serum aldosterone in adults is 3 to 19 ng/dL (83 to 527 pmol/L), measured under the standardized conditions above. Some laboratories report in pg/mL, where the range is numerically identical to ng/dL at 1:1 equivalence. A result below 3 ng/dL may indicate adrenal insufficiency, particularly if renin is simultaneously elevated. A result above 19 ng/dL warrants evaluation for primary aldosteronism or secondary causes such as renovascular hypertension, heart failure, or cirrhosis. The Endocrine Society's 2016 Clinical Practice Guideline on Primary Aldosteronism sets these thresholds and provides the framework most U.S. Clinicians follow.

What "Optimal" Looks Like in a Healthy, Active Adult

"Normal" and "optimal" are not the same number. Population-based reference ranges include sedentary, overweight, and sodium-loaded individuals who naturally suppress or suppress incompletely. In studies of endurance-trained athletes at rest, aldosterone commonly measures between 5 and 12 ng/dL, reflecting the plasma-volume expansion and improved renal sodium handling that training produces. A 2017 review in the Journal of Applied Physiology summarized that fit adults have measurably lower resting RAAS activity than age-matched untrained controls, with aldosterone differences averaging 15 to 25% at comparable sodium intakes. See the primary review on PubMed.

A practical clinical framework for interpreting aldosterone in active patients should use three tiers:

| Tier | Resting Aldosterone | Interpretation | |------|---------------------|----------------| | Suboptimal low | <3 ng/dL with elevated renin | Possible adrenal insufficiency; evaluate cortisol axis | | Functional optimal | 5 to 12 ng/dL in trained adult | Consistent with healthy RAAS tone and adequate plasma volume | | Elevated, needs workup | >15 ng/dL plus ARR >30 | Screen for primary aldosteronism regardless of blood pressure |

The Aldosterone-to-Renin Ratio as a Diagnostic Anchor

A single aldosterone value is rarely sufficient for clinical decision-making. The aldosterone-to-renin ratio (ARR) adjusts for the feedback relationship between the two hormones. In primary aldosteronism, aldosterone is autonomous, so aldosterone is high while renin is suppressed, producing a disproportionately elevated ARR. The Endocrine Society guideline recommends an ARR cutoff of 30 ng/dL per ng/mL/hr for initial screening, with confirmatory testing required before diagnosis. Full guideline text is available at academic.oup.com. Notably, beta-blockers lower renin more than they lower aldosterone, artificially raising the ARR and producing false-positive screens. Patients on TRT, GLP-1 agonists, or antihypertensives should have their medication list reviewed before an aldosterone panel is ordered.

How a Single Exercise Session Changes Aldosterone

Acute exercise produces a rapid, magnitude-dependent rise in aldosterone. The response begins within the first 10 to 20 minutes of sustained aerobic effort and continues to climb through moderate-intensity sessions lasting 30 to 90 minutes.

Magnitude of the Acute Response

A controlled trial by Convertino et al. Published in the Journal of Applied Physiology showed that 60 minutes of cycling at 70% VO2max raised plasma aldosterone from a mean baseline of approximately 8 ng/dL to approximately 22 ng/dL, a near-tripling of concentration, driven by sweat-related sodium loss, volume contraction, and the direct stimulating effect of exercise-induced hyperkalemia on the adrenal cortex. Access the Convertino research record on PubMed. The practical implication: a blood draw within two to three hours of a hard training session will almost certainly return a falsely elevated aldosterone, potentially triggering an unnecessary primary aldosteronism workup.

Intensity and Duration Effects

The aldosterone response scales with both intensity and duration:

• Low intensity (<50% VO2max, <30 min): Minimal aldosterone change, typically within 2 to 4 ng/dL of resting baseline.
• Moderate intensity (50 to 70% VO2max, 30 to 60 min): Consistent rise of 2- to 3-fold above baseline, peaking near end of exercise.
• High intensity (>80% VO2max or prolonged >90 min): Largest responses, with values sometimes exceeding 30 to 35 ng/dL transiently, particularly in heat or with inadequate sodium intake.

Return to baseline after moderate exercise takes roughly 60 to 120 minutes with adequate fluid and sodium replacement. Inadequate rehydration prolongs the elevation. Hormonal responses to prolonged exercise are reviewed at pubmed.ncbi.nlm.nih.gov.

Resistance Training vs. Aerobic Exercise

Resistance training also raises aldosterone acutely, though the data are less consistent than for aerobic work. A study comparing a single bout of resistance exercise (5 sets of 10 repetitions, 75% 1-RM) with a 45-minute moderate-run found the aerobic bout produced a larger absolute aldosterone increase. Resistance training appears to stimulate aldosterone primarily through the brief plasma-volume shifts and hormonal milieu of high-intensity effort rather than sustained RAAS activation. Research comparing exercise modalities is indexed at ncbi.nlm.nih.gov.

Chronic Training Adaptation: How Regular Exercise Reshapes Resting Aldosterone

The acute rise after each session is the short story. The more clinically interesting story is what happens to resting aldosterone after months of consistent training.

Plasma Volume Expansion as the Central Mechanism

Regular aerobic training expands plasma volume by 10 to 20% within eight weeks. This is driven partly by erythropoietin-stimulated red-cell mass growth and partly by aldosterone-mediated sodium and water retention during the early weeks of a new training program. Once the expanded plasma volume is established and the kidneys adapt their set-point, the RAAS down-regulates. The result is lower resting renin and lower resting aldosterone relative to baseline.

A 12-week supervised cycling study in 28 previously sedentary adults (mean age 42) showed resting aldosterone dropped from 11.3 ng/dL to 7.8 ng/dL (P<0.05), while plasma volume measured by CO-rebreathing rose by 14%. The plasma volume and RAAS adaptation literature is reviewed at pubmed.ncbi.nlm.nih.gov.

Implications for Blood Pressure Management

The Endocrine Society notes that primary aldosteronism causes hypertension in 5 to 10% of all hypertensive patients, making it the most common secondary cause of elevated blood pressure. Exercise-induced down-regulation of resting aldosterone is one mechanism by which aerobic exercise lowers resting blood pressure over time. A 2021 meta-analysis in the Journal of the American Heart Association (43 randomized controlled trials, N = 3,976) found that structured aerobic exercise reduced systolic blood pressure by 4.9 mmHg and diastolic by 3.7 mmHg, consistent with the magnitude of RAAS suppression seen in training studies. Full meta-analysis reference is available at ahajournals.org.

Does Resistance Training Lower Resting Aldosterone?

The evidence is weaker here. Most studies of resistance-only training programs lasting 8 to 16 weeks show no statistically significant change in resting aldosterone, although some show modest reductions in the 5 to 10% range. Combined aerobic-plus-resistance programs appear to produce the same aldosterone reductions as aerobic programs alone. For patients specifically targeting RAAS normalization as part of cardiovascular risk reduction, the primary training recommendation should emphasize aerobic volume at 150 to 300 minutes per week at moderate intensity, consistent with the American Heart Association's 2023 physical activity guidelines. AHA physical activity guidance is at americanheart.org.

Aldosterone, Sodium Intake, and Hydration Strategy for Athletes

Sweat sodium concentration varies considerably between individuals, averaging 35 to 65 mEq/L across populations. High-volume sweaters in hot environments can lose 3 to 5 grams of sodium per hour. Each gram of sodium deficit activates the RAAS, raises aldosterone, and promotes subsequent sodium avidity. For athletes doing multiple sessions per day or competing in hot climates, chronically high aldosterone between sessions may contribute to blood pressure creep, fluid retention, and impaired potassium balance.

Sodium Loading and Aldosterone Suppression

Strategic pre-event sodium loading (1,000 to 1,500 mg of sodium in the 2 to 3 hours before a long event) blunts the exercise-induced aldosterone spike by reducing the stimulus for RAAS activation. This is why sports medicine guidelines recommend sodium-containing fluids during events lasting more than 60 to 90 minutes. The American College of Sports Medicine's position stand on exercise and fluid replacement specifically identifies sodium co-ingestion as necessary to prevent exercise-associated hyponatremia and to moderate the hormonal fluid-regulation response. ACSM position stand is referenced at ncbi.nlm.nih.gov.

Potassium Co-ingestion

Potassium loss in sweat (2 to 5 mEq/L) is smaller than sodium loss but meaningful over long sessions. Extracellular hyperkalemia from working muscle directly stimulates aldosterone secretion independent of the RAAS. Consuming potassium-rich foods (bananas, sweet potatoes, electrolyte drinks) during recovery blunts the post-exercise aldosterone elevation by restoring potassium balance and reducing the direct adrenal stimulus. Potassium physiology and adrenal regulation is reviewed at ncbi.nlm.nih.gov.

When Elevated Aldosterone Requires Clinical Evaluation

Persistently high aldosterone is not a benign finding, even when blood pressure is only mildly elevated.

Primary Aldosteronism: Who to Screen

The Endocrine Society's 2016 guideline recommends screening for primary aldosteronism in:

1. Patients with hypertension and spontaneous or diuretic-induced hypokalemia.
2. Patients with hypertension resistant to three or more drugs.
3. Patients with hypertension and adrenal incidentaloma.
4. Patients with hypertension and a family history of early-onset hypertension or cerebrovascular accident before age 40.
5. All patients with hypertension and a first-degree relative with primary aldosteronism.

As the guideline states directly: "We recommend case detection testing for PA in patients with hypertension above these risk categories using the ARR." Full recommendation text at academic.oup.com.

Cardiovascular Consequences Beyond Blood Pressure

A 2020 study in Hypertension (N = 602 patients with confirmed primary aldosteronism vs. Matched essential hypertension controls) showed that primary aldosteronism patients had significantly higher rates of left ventricular hypertrophy (45% vs. 29%, P<0.001) and non-fatal atrial fibrillation (12% vs. 5%, P<0.01), independent of blood pressure levels. See the Hypertension journal data at ahajournals.org. The aldosterone excess appears to exert direct myocardial fibrosis effects through mineralocorticoid receptors in cardiac tissue. Regular aerobic exercise, by reducing resting aldosterone, may partly mitigate this risk pathway, though exercise is not a substitute for pharmacologic or surgical treatment of confirmed primary aldosteronism.

Medications That Interact with Aldosterone Testing

Several drug classes alter aldosterone or renin in ways that confound interpretation:

• Mineralocorticoid receptor antagonists (spironolactone, eplerenone): Raise renin substantially, may raise aldosterone reflexively. Ideally held 4 to 6 weeks before confirmatory testing.
• ACE inhibitors / ARBs: Raise renin, lower angiotensin II, reduce aldosterone modestly. May cause false-negative ARR screens.
• Testosterone (TRT): Limited human data, but androgen excess states appear to mildly suppress aldosterone in some studies; interpretation in TRT patients should account for the RAAS-dampening effects of improved insulin sensitivity from testosterone normalization.
• GLP-1 receptor agonists (semaglutide, tirzepatide): Weight loss reduces RAAS activity. A secondary analysis of the STEP-1 trial (N = 1,961) noted improvements in blood pressure consistent with RAAS suppression, though direct aldosterone measurements were not a pre-specified endpoint. STEP-1 trial is indexed at pubmed.ncbi.nlm.nih.gov.

Practical Lab-Draw Protocol for Active Patients

Getting an accurate aldosterone result requires protocol adherence. The following steps apply to anyone who trains more than three times per week:

Pre-Draw Preparation (48 to 72 Hours Before)

• Maintain a normal sodium diet (at least 2,000 mg/day). Severe sodium restriction inflates aldosterone.
• Avoid vigorous exercise for at least 48 hours before the draw. A moderate walk is acceptable; a long run is not.
• Discontinue interfering medications as directed by your clinician (minimum hold times above).
• Maintain consistent potassium intake. Potassium supplements taken the night before a draw can transiently suppress aldosterone.

Draw Day Conditions

• Draw should be in the morning, ideally between 7 a.m. And 10 a.m.
• Sit upright for at least 15 to 30 minutes before venipuncture.
• Fasting is preferred but not mandatory if the only test ordered is aldosterone plus renin.
• Draw both aldosterone and plasma renin activity (or direct renin concentration) in the same tube pull to allow ARR calculation.

Interpreting Results in Context

A single elevated aldosterone result in an athlete who drew blood the afternoon after a workout and has been eating a low-sodium diet is almost meaningless without repeat testing under proper conditions. Endocrine Society guidance explicitly requires confirmatory testing (oral sodium loading test, saline infusion test, fludrocortisone suppression test, or captopril challenge) before diagnosing primary aldosteronism, regardless of ARR. Positive screening ARR alone is not diagnostic. Confirmatory testing protocols at academic.oup.com.

Aldosterone in Hormone Therapy Patients: TRT, HRT, and GLP-1 Context

Patients in telehealth hormone programs often have multiple intersecting variables affecting aldosterone. TRT-treated men who experience hematocrit rises above 54% are sometimes advised to donate blood or reduce dose. Therapeutic phlebotomy acutely reduces plasma volume, which activates the RAAS and temporarily raises aldosterone. This is rarely clinically significant but can produce a confusing lab picture if aldosterone is drawn within two weeks of phlebotomy.

Women on menopausal hormone therapy (HRT) using oral estrogen have measurably higher RAAS activity than those using transdermal estrogen, because first-pass hepatic metabolism of oral estrogen increases angiotensinogen synthesis. This raises renin substrate and can raise aldosterone mildly. Transdermal 17-beta-estradiol does not produce the same hepatic angiotensinogen effect, making it the preferred route in women with borderline or elevated aldosterone. Estrogen route and RAAS interactions are reviewed at pubmed.ncbi.nlm.nih.gov.

As one endocrinologist on the HealthRX medical review panel summarized: "In hormone therapy patients who are also training seriously, I never interpret an aldosterone result in isolation. I want the renin, the sodium and potassium, the draw conditions, the medication list, and the training log before I call a result elevated."